3rd Quarter - Amendment

AMERICA'S BLOOD CENTERS for AMERICA'S BLOOD CENTERS

Firm
Client
Income
—
Expenses
$21,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2011 $21,000 Replaced
3rd Quarter - Amendment (this page) Dec 14, 2012 $21,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Blood center inclusion in H.R. 5, Help, Efficient, Accessible, Low-Cost, Timely Health Care Act

LobbyistCovered position, as disclosed
ROBERT KAPLER —
JAMES MACPHERSON —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5 (112th)

Medicare/Medicaid MMM

Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) and Health Care and Education Reconciliation Act (P.L. 111-152)

LobbyistCovered position, as disclosed
ROBERT KAPLER —
JAMES MACPHERSON —

Contacted: Treasury, Dept of; SENATE; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

House and Senate FY 2012 Labor/HHS/Education Appropriations bill: C.W. Bill Young Cell Transplantation Program; National Cord Blood Inventory.

LobbyistCovered position, as disclosed
ROBERT KAPLER —
JAMES MACPHERSON —

Contacted: Treasury, Dept of; Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.